Skip to main content

Statine, Ezetimib, Bempedoinsäure und PCSK9-Hemmer sequenziell

Lipidtherapie zur kardiovaskulären Prävention bei Diabetes mellitus

This is a preview of subscription content, access via your institution.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Martin Merkel.

Supplementary Information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Merkel, M. Lipidtherapie zur kardiovaskulären Prävention bei Diabetes mellitus . Info Diabetol 15, 29–31 (2021). https://doi.org/10.1007/s15034-021-3699-8

Download citation